Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Scynexis (SCYX) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Scynexis (SCYX) over the last 10 years, with Q3 2025 value amounting to $49.9 million.

  • Scynexis' Shares Outstanding (Diluted Average) rose 263.31% to $49.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.9 million, marking a year-over-year increase of 263.31%. This contributed to the annual value of $42.6 million for FY2022, which is 6150.83% up from last year.
  • According to the latest figures from Q3 2025, Scynexis' Shares Outstanding (Diluted Average) is $49.9 million, which was up 263.31% from $49.7 million recorded in Q2 2025.
  • Over the past 5 years, Scynexis' Shares Outstanding (Diluted Average) peaked at $49.9 million during Q3 2025, and registered a low of $26.4 million during Q4 2021.
  • Its 4-year average for Shares Outstanding (Diluted Average) is $44.3 million, with a median of $48.6 million in 2024.
  • As far as peak fluctuations go, Scynexis' Shares Outstanding (Diluted Average) surged by 6150.83% in 2022, and later skyrocketed by 255.04% in 2025.
  • Scynexis' Shares Outstanding (Diluted Average) (Quarter) stood at $26.4 million in 2021, then skyrocketed by 61.51% to $42.6 million in 2022, then grew by 14.09% to $48.6 million in 2024, then grew by 2.63% to $49.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $49.9 million in Q3 2025, compared to $49.7 million in Q2 2025 and $48.6 million in Q3 2024.